Registratie BioNTech in lobbyregister EU

1. 12/25/2020 Transparency Register - Search the register
https://ec.europa.eu/transparencyregister/public/consultation/displaylobbyist.do?id=516273537966-42 1/5
 Profile of registrant
 Registrant : Organisation or self-employed individual
 Section of registration
 Contact details
BioNTech SE
Identification number in the register: 516273537966-42
Registration date: 04/05/2020 15:59:54
The registrant performed the last (partial or annual) update on: 07/05/2020 13:10:10
The date of the last annual update was: 04/05/2020 15:59:54
Next annual update due latest on: 04/05/2021
(Organisation) name:
BioNTech SE
Acronym:
Legal status:
Societas Europaea
Website:
https://biontech.de/
Section:
II - In-house lobbyists and trade/business/professional associations
and more precisely:
Companies & groups
Contact details of organisation's head office:
An der Goldgrube 12
Mainz 55131
GERMANY
Transparency Register

2. 12/25/2020 Transparency Register - Search the register
https://ec.europa.eu/transparencyregister/public/consultation/displaylobbyist.do?id=516273537966-42 2/5
 Person with legal responsibility
 Person in charge of EU relations
 Goals / remit
 Specific activities covered by the Register
Telephone number:
(+49)6131 90840
Name, Surname:
Mr Sierk Poetting
Position:
CFO
Name, Surname:
Mr Sierk Poetting
Position:
CFO
Goals / remit of the organisation:
Biopharmaceutical New Technologies (BioNTech) is a next generation immunotherapy company
pioneering novel therapies for cancer and other serious diseases. The company exploits a wide array of
computational discovery and therapeutic drug platforms for the rapid development of novel
biopharmaceuticals. Its broad portfolio of oncology product candidates includes
individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bi-
specific checkpoint immuno-modulators, targeted cancer antibodies and small molecules. Based on its
deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and
its collaborators are developing multiple mRNA vaccine candidates for a range infectious diseases
alongside its diverse oncology pipeline. BioNTech has established
a broad set of relationships with multiple global pharmaceutical collaborators, including Eli Lilly
and Company, Genmab, Sanofi, Bayer Animal Health, Genentech, a (...)
The organisation is active on the following level(s):
Global

3. 12/25/2020 Transparency Register - Search the register
https://ec.europa.eu/transparencyregister/public/consultation/displaylobbyist.do?id=516273537966-42 3/5
 Number of persons involved in the activities described in the box
above
Main EU legislative proposals or policies targeted:
Interactions with the European Commission and the European Investment Bank regarding activities
relating to mRNA drugs and vaccines, including financial support for increasing manufacturing capacity
of such drugs and vaccines.
Relevant policy implementation, public relations and communication activities such as
projects, events and publications:
N/A
List of meetings with the European Commission :
N/A
List of contributions to public consultations :
N/A
List of contributions to roadmaps :
N/A
Participation in EU structures and platforms
Intergroups and unofficial groupings (European Parliament) :
N/A
Commission Expert Groups And Other Similar Entities (European Commission) :
N/A
Complementary information:
N/A
Number of persons involved from the organisation expressed in % of working time:
25%: 2
Number of persons involved:
2
Full time equivalent (FTE):
0.5
Complementary information:
N/A

4. 12/25/2020 Transparency Register - Search the register
https://ec.europa.eu/transparencyregister/public/consultation/displaylobbyist.do?id=516273537966-42 4/5
 Persons accredited for access to European Parliament premises
 Fields of interest
 Membership and affiliation
 Financial data
No accredited persons
The organisation's fields of interests are:
Public Health
Research and innovation
Member organisations:
Membership of any associations/(con)federations/networks or other bodies:
Bio Deutschland e.V.
BME e.V.
Gesundheitswirtschaft Rhein-Main e.V.
Research Quality Association Ltd
DIRK - Deutscher Investor Relations Verband e.V.
CI3 e.V.
Mainzer Wissenschaftsallianz e.V.
Verband Forschender Arzneimittelhersteller e.V.
IHK - Industrie- und Handelskammer für Rheinhessen
Kita BioRegio e. V.
Financial year:
01/2019 - 12/2019
Estimate of the annual costs related to activities covered by the register:
50,000 € - 99,999 €
Most recent financial information about funding received from the EU institutions:
Procurement:
€
Source:

5. 12/25/2020 Transparency Register - Search the register
https://ec.europa.eu/transparencyregister/public/consultation/displaylobbyist.do?id=516273537966-42 5/5
 Code of conduct
By its registration the organisation has signed the Transparency Register Code of Conduct.
Grants:
50,962,375 €
Source:
Horizon 2020; FP7 (7th Framework Programme); EIB loan
Other (financial) information provided by the organisation:
N/A